Nothing Special   »   [go: up one dir, main page]

DK3473621T3 - Fremgangsmåde til fremstilling af diphenylmethan-derivat - Google Patents

Fremgangsmåde til fremstilling af diphenylmethan-derivat Download PDF

Info

Publication number
DK3473621T3
DK3473621T3 DK17813615.6T DK17813615T DK3473621T3 DK 3473621 T3 DK3473621 T3 DK 3473621T3 DK 17813615 T DK17813615 T DK 17813615T DK 3473621 T3 DK3473621 T3 DK 3473621T3
Authority
DK
Denmark
Prior art keywords
diphenylmethan
derivative
preparing
preparing diphenylmethan
diphenylmethan derivative
Prior art date
Application number
DK17813615.6T
Other languages
English (en)
Inventor
Hee-Kyoon Yoon
Se-Hwan Park
Ji-Sung Yoon
Soongyu Choi
Hee Jeong Seo
Eun-Jung Park
Younggyu Kong
Kwang-Seop Song
Min Ju Kim
So Ok Park
Original Assignee
Dae Woong Pharma
Green Cross Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Dae Woong Pharma, Green Cross Corp filed Critical Dae Woong Pharma
Application granted granted Critical
Publication of DK3473621T3 publication Critical patent/DK3473621T3/da

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D407/00Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00
    • C07D407/02Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings
    • C07D407/04Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/08Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B01PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01DSEPARATION
    • B01D9/00Crystallisation
    • B01D9/005Selection of auxiliary, e.g. for control of crystallisation nuclei, of crystal growth, of adherence to walls; Arrangements for introduction thereof
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D307/00Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/77Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D307/78Benzo [b] furans; Hydrogenated benzo [b] furans
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D409/00Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/04Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07BGENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B2200/00Indexing scheme relating to specific properties of organic compounds
    • C07B2200/13Crystalline forms, e.g. polymorphs
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07BGENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B51/00Introduction of protecting groups or activating groups, not provided for in the preceding groups
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02PCLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00Technologies relating to chemical industry
    • Y02P20/50Improvements relating to the production of bulk chemicals
    • Y02P20/55Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Diabetes (AREA)
  • General Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Emergency Medicine (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Endocrinology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Saccharide Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pyrane Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
DK17813615.6T 2016-06-17 2017-06-15 Fremgangsmåde til fremstilling af diphenylmethan-derivat DK3473621T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
KR20160075910 2016-06-17
PCT/KR2017/006271 WO2017217792A1 (ko) 2016-06-17 2017-06-15 다이페닐메탄 유도체의 제조방법

Publications (1)

Publication Number Publication Date
DK3473621T3 true DK3473621T3 (da) 2021-09-06

Family

ID=60664449

Family Applications (2)

Application Number Title Priority Date Filing Date
DK20152959.1T DK3663292T3 (da) 2016-06-17 2017-06-15 Diphenylmethan-derivat i krystallinsk form
DK17813615.6T DK3473621T3 (da) 2016-06-17 2017-06-15 Fremgangsmåde til fremstilling af diphenylmethan-derivat

Family Applications Before (1)

Application Number Title Priority Date Filing Date
DK20152959.1T DK3663292T3 (da) 2016-06-17 2017-06-15 Diphenylmethan-derivat i krystallinsk form

Country Status (30)

Country Link
US (2) US10640496B2 (da)
EP (2) EP3663292B1 (da)
JP (4) JP6763978B2 (da)
KR (2) KR102233229B1 (da)
CN (2) CN109311861B (da)
AU (1) AU2017285813B2 (da)
BR (1) BR112018076243A2 (da)
CA (2) CA3081033C (da)
CL (1) CL2018003645A1 (da)
CO (1) CO2018014018A2 (da)
DK (2) DK3663292T3 (da)
DO (1) DOP2018000287A (da)
EC (1) ECSP19000185A (da)
ES (2) ES2891825T3 (da)
HR (1) HRP20211670T8 (da)
HU (1) HUE056428T2 (da)
MA (2) MA50774B1 (da)
MX (2) MX2018015647A (da)
MY (1) MY203941A (da)
NZ (1) NZ749398A (da)
PE (2) PE20240590A1 (da)
PH (1) PH12018550206A1 (da)
PL (2) PL3473621T3 (da)
PT (2) PT3663292T (da)
RS (1) RS62550B1 (da)
SA (2) SA518400666B1 (da)
SG (2) SG11201811154QA (da)
SI (1) SI3663292T1 (da)
TN (1) TN2018000437A1 (da)
WO (1) WO2017217792A1 (da)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE102011054773A1 (de) 2011-10-25 2013-04-25 Vb Autobatterie Gmbh & Co. Kgaa Anschlusspol für einen Akkumulator, Akkumulatorgehäuse und Maschine zur Herstellung eines Anschlusspols
BR112021002523A2 (pt) 2018-08-13 2021-05-04 Daewoong Pharmaceutical Co., Ltd. método para preparar um composto
CN112341416A (zh) * 2019-08-09 2021-02-09 天津津艺医药科技发展有限责任公司 一种制备苯并含氧脂杂环衍生物的方法
KR102572714B1 (ko) 2020-02-27 2023-08-31 주식회사 대웅제약 Sglt 저해제의 합성에 유용한 중간체 및 이를 이용한 sglt 저해제의 제조 방법
CN112094253B (zh) * 2020-09-10 2023-01-10 株式会社大熊制药 用于制备sglt抑制剂中间体的合成方法
JP7527478B2 (ja) 2020-09-10 2024-08-02 デーウン ファーマシューティカル カンパニー リミテッド Sglt阻害剤中間体の合成方法
CN113200860B (zh) * 2021-04-29 2024-07-30 爱斯特(成都)生物制药股份有限公司 一种sglt2抑制剂中间体的制备方法
CN113801010A (zh) * 2021-11-18 2021-12-17 山东诚创蓝海医药科技有限公司 一种5-溴-2-氯苯甲酸的制备方法
CN113912487B (zh) * 2021-11-23 2024-05-28 山东研峰新材料科技有限公司 一种2,5-双卤代苯甲酸的合成方法
KR20230110001A (ko) 2022-01-14 2023-07-21 주식회사 대웅제약 Ssglt 저해제의 합성에 유용한 중간체의 제조 방법
KR20240044194A (ko) * 2022-09-28 2024-04-04 주식회사 대웅제약 이나보글리플로진의 신규한 공결정
KR20240044190A (ko) 2022-09-28 2024-04-04 주식회사 대웅제약 이나보글리플로진의 신규한 결정형 및 이의 제조방법
WO2024136385A1 (ko) 2022-12-21 2024-06-27 주식회사 대웅테라퓨틱스 이나보글리플로진을 포함하는 점안제 형태의 약학 조성물

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4966907A (en) * 1988-08-12 1990-10-30 Merck & Co., Inc. 6-substituted 5-hydroxy-2,3-dihydrobenzofurans as inhibitors of leukotriene biosynthesis
EA015104B1 (ru) * 2003-08-01 2011-06-30 Мицубиси Танабе Фарма Корпорейшн Новые соединения, обладающие ингибирующей активностью в отношении натрийзависимого транспортера
CA2694029C (en) 2007-07-26 2016-10-04 Lexicon Pharmaceuticals, Inc. Methods and compounds useful for the preparation of sodium glucose co-transporter 2 inhibitors
TW201018695A (en) 2008-07-30 2010-05-16 Ferrer Int 1,6-dihydro-2H-3-oxa-6-aza-as-indacene compounds
US8163704B2 (en) 2009-10-20 2012-04-24 Novartis Ag Glycoside derivatives and uses thereof
WO2012041898A1 (en) * 2010-09-29 2012-04-05 Celon Pharma Sp. Z O.O. Combination of sglt2 inhibitor and a sugar compound for the treatment of diabetes
JP5876570B2 (ja) * 2011-06-01 2016-03-02 グリーン・クロス・コーポレイションGreen Cross Corp. Sglt2阻害剤としての新規のジフェニルメタン誘導体
US9340521B2 (en) * 2013-03-18 2016-05-17 Green Cross Corporation Method for dual inhibition of SGLT1 and SGLT2 using diphenylmethane derivatives
FR3017868A1 (fr) * 2014-02-21 2015-08-28 Servier Lab Derives d'isoquinoleine, leur procede de preparation et les compositions pharmaceutiques qui les contiennent

Also Published As

Publication number Publication date
US20190169174A1 (en) 2019-06-06
PH12018550206A1 (en) 2019-09-30
EP3473621B1 (en) 2021-08-04
SI3663292T1 (sl) 2022-01-31
JP2021152054A (ja) 2021-09-30
RS62550B1 (sr) 2021-12-31
EP3663292A1 (en) 2020-06-10
JP6763978B2 (ja) 2020-09-30
AU2017285813A1 (en) 2019-01-17
CA3081033A1 (en) 2017-12-21
JP7352509B2 (ja) 2023-09-28
RU2019101056A3 (da) 2020-07-17
CL2018003645A1 (es) 2019-03-22
KR102233229B1 (ko) 2021-03-29
JP2023145481A (ja) 2023-10-11
US10889574B2 (en) 2021-01-12
MA44545B1 (fr) 2020-05-29
SG11201811154QA (en) 2019-01-30
MY203941A (en) 2024-07-25
JP2019521985A (ja) 2019-08-08
DOP2018000287A (es) 2019-03-31
TN2018000437A1 (en) 2020-06-15
HUE056428T2 (hu) 2022-02-28
ECSP19000185A (es) 2019-01-31
PL3473621T3 (pl) 2022-01-10
HRP20211670T1 (hr) 2022-02-18
MA50774A1 (fr) 2021-03-31
SG10201911782RA (en) 2020-02-27
KR20170142904A (ko) 2017-12-28
CO2018014018A2 (es) 2019-03-08
MX2021008988A (es) 2022-05-05
CN109311861A (zh) 2019-02-05
MA44545A1 (fr) 2019-10-31
MX2018015647A (es) 2019-04-11
PT3473621T (pt) 2021-10-04
KR20210036892A (ko) 2021-04-05
RU2019101056A (ru) 2020-07-17
AU2017285813B2 (en) 2020-02-06
ES2891825T3 (es) 2022-01-31
CN113651803B (zh) 2022-10-28
RU2021129636A (ru) 2021-11-22
NZ749398A (en) 2020-01-31
EP3473621A4 (en) 2020-03-11
MA50774B1 (fr) 2022-02-28
SA521422474B1 (ar) 2023-11-02
KR102379584B1 (ko) 2022-03-29
SA518400666B1 (ar) 2021-11-30
EP3663292B1 (en) 2021-09-01
EP3473621A1 (en) 2019-04-24
BR112018076243A2 (pt) 2019-03-26
US20190382390A1 (en) 2019-12-19
DK3663292T3 (da) 2021-10-25
CA3026756A1 (en) 2017-12-21
WO2017217792A1 (ko) 2017-12-21
MA44545B2 (fr) 2020-11-30
PE20240590A1 (es) 2024-03-21
CA3026756C (en) 2021-03-02
PE20190467A1 (es) 2019-04-04
PT3663292T (pt) 2021-11-08
CN109311861B (zh) 2021-08-24
CA3081033C (en) 2022-04-12
JP2020117528A (ja) 2020-08-06
CN113651803A (zh) 2021-11-16
PL3663292T3 (pl) 2022-01-17
ES2898336T3 (es) 2022-03-07
US10640496B2 (en) 2020-05-05
HRP20211670T8 (hr) 2022-03-18

Similar Documents

Publication Publication Date Title
DK3473621T3 (da) Fremgangsmåde til fremstilling af diphenylmethan-derivat
DK3315610T3 (da) Fremgangsmåde til fremstilling af fucosylerede oligosaccharider
DK3292134T3 (da) Metode til dyrkning af akkermansia
DK3282836T3 (da) Fremgangsmåde til opdræt af insekter
DK3402773T3 (da) Fremgangsmåde til fremstilling af methanol
DK3294885T3 (da) Fremgangsmåde til at fremstille rna
DK3262071T3 (da) Fremgangsmåde til anvendelse af anti-CD79b-immunkonjugater
DK3192902T3 (da) Fremgangsmåde til fremstilling af graphenholdige viscosefibre
DK3096741T3 (da) Fremgangsmåde til fremstillingen af hybridosomer
DK3294700T3 (da) Fremgangsmåde til fremstilling af limonen-4-ol
DK3234131T3 (da) Fremgangsmåde til screening af kiral toksicitet
DK3325443T3 (da) Fremgangsmåde til fremstilling af pridopidin
DK3317400T3 (da) Fremgangsmåde til kryokonservering af tumorinfiltrerende lymfocytter
DK3515990T3 (da) Fremgangsmåde til fremstilling af lignocellulosematerialer
DK3174858T3 (da) Fremgangsmåde til fremstilling af pyrazoler
DK3122444T3 (da) Fremgangsmåde til fremstilling af membraner
DK3287523T3 (da) Fremgangsmåde til sekretorisk fremstilling af protein
DK3529233T3 (da) Fremgangsmåde til fremstilling af 3-alkylsulfanyl-2-chlor-n-(1-alkyl-1h-tetrazol-5-yl)-4-trifluoromethyl-benzamider
DK3166927T3 (da) Fremgangsmåde til fremstilling af 4-alkoxy-3-hydroxy-picolinsyre
DK3487443T3 (da) Fremgangsmåde til opmåling af en implantat-implantat-situation
DK3191498T3 (da) Fremgangsmåde til fremstilling af 2'-o-fucosyllactose
DK3280408T3 (da) Fremgangsmåde til fremstilling af dicycloplatin
DK3346990T3 (da) Fremgangsmåde til stråleformaling
DK3137449T3 (da) Fremgangsmåder til fremstilling af substituerede cycloseriner
DK3295941T3 (da) Fremgangsmåde til fremstilling af form a af grapiprant